A new technique using infrared imaging has been developed that could make grading tumour biopsies – and therefore cancer diagnosis – more accurate and reliable
Keely Portway looks at the trials and tribulations of bringing new technology to market, particularly in a pandemic
Prof Dr Bernd Jähne, chair of EMVA 1288 and senior professor at HCI, Heidelberg University, gives a preview of release 4.0 of the EMVA standard 1288
Anne Wendel, director of VDMA Machine Vision, on the difficulties the machine vision sector is facing, and why there are still plenty of positives
Vision Ventures’ director Dr Chris Yates on what the future holds for M&A activity in machine vision
As a new academic year begins, Greg Blackman finds out what students taking image processing courses in two universities have in store
Géraldine Andrieux, CEO of Blumorpho
Ahead of the Inpho Venture Summit in October, Blumorpho CEO, Géraldine Andrieux, discusses how startups should approach pitching for venture capital funding in these uncertain economic times
Greg Blackman speaks to Simon Beveridge, managing director of UK-based vision integrator Siga Vision, about installing vision systems during Covid-19
Some of Luminate's third cohort of startups. Credit: Luminate
On 14 September, 10 photonics startups from Luminate's business accelerator will present their technology during The Optical Society’s virtual conference. Greg Blackman asks Luminate MD, Sujatha Ramanujan, how these young companies are coping during Covid-19
Credit: Messe Stuttgart
Greg Blackman gathers opinion from the vision community on the impact the cancellation of Vision Stuttgart has on product releases and connecting with customers
